These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 20560861
1. Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing. Vijgen S, Nys S, Naesens R, Magerman K, Boel A, Cartuyvels R. Med Mycol; 2011 Jan; 49(1):107-10. PubMed ID: 20560861 [Abstract] [Full Text] [Related]
2. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164 [Abstract] [Full Text] [Related]
3. [Evaluation of the VITEK 2 system (AST-YSO1 cards) for antifungal susceptibility testing against different Candida species]. Ochiuzzi ME, Arechavala A, Guelfand L, Maldonado I, Soloaga R, Red de Micología CABA, Argentina. Rev Argent Microbiol; 2014 Sep; 46(2):111-8. PubMed ID: 25011594 [Abstract] [Full Text] [Related]
4. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet PJ, Rispail P, Lachaud L. J Clin Microbiol; 2010 Jan; 48(1):154-61. PubMed ID: 19889902 [Abstract] [Full Text] [Related]
5. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study. Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna MT, Morace G. J Clin Microbiol; 2010 Sep; 48(9):3153-7. PubMed ID: 20631105 [Abstract] [Full Text] [Related]
6. Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii. Zhang M, Zhou Z, Wang D, Zhou A, Song G, Chen X, Guo J, Wu W. Med Mycol; 2022 Mar 04; 60(3):. PubMed ID: 35099022 [Abstract] [Full Text] [Related]
7. [Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010]. Porte L, León P, Gárate C, Guzmán AM, Labarca J, García P. Rev Chilena Infectol; 2012 Apr 04; 29(2):149-55. PubMed ID: 22689028 [Abstract] [Full Text] [Related]
8. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. J Clin Microbiol; 2015 Jun 04; 53(6):1823-30. PubMed ID: 25809970 [Abstract] [Full Text] [Related]
9. Candida auris - Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing - A single centre experience. Patwardhan SA, Prayag PS, Soman RN, Purandare BD, Ramya S, Dawra R, Joshi R, Prayag AP. Indian J Med Microbiol; 2024 Jun 04; 50():100618. PubMed ID: 38795936 [Abstract] [Full Text] [Related]
14. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. J Clin Microbiol; 2007 Mar 04; 45(3):796-802. PubMed ID: 17215344 [Abstract] [Full Text] [Related]
15. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. J Clin Microbiol; 2007 Jan 04; 45(1):70-5. PubMed ID: 17079501 [Abstract] [Full Text] [Related]
16. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. Quindós G, Sánchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hernández-Almaraz JL. Int J Antimicrob Agents; 2008 Mar 04; 31(3):266-71. PubMed ID: 18054468 [Abstract] [Full Text] [Related]
17. Evaluation of two commercial methods for the susceptibility testing of Candida species: Vitek 2® and Sensititre YeastOne®. Siqueira RA, Doi AM, de Petrus Crossara PP, Koga PCM, Marques AG, Nunes FG, Pasternak J, Martino MDV. Rev Iberoam Micol; 2018 Mar 04; 35(2):83-87. PubMed ID: 29580699 [Abstract] [Full Text] [Related]
19. Broth medium for microdilution susceptibility tests of fluconazole and voriconazole. Barry A, Brown S, Traczewski M. Eur J Clin Microbiol Infect Dis; 2002 May 04; 21(5):407-10. PubMed ID: 12072930 [No Abstract] [Full Text] [Related]
20. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study. J Clin Microbiol; 2007 Jun 04; 45(6):1735-45. PubMed ID: 17442797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]